在2026年3月,Medtronic的MiniMed在糖尿病率上升和市场增长的情况下向公众推出可穿戴胰岛素. In March 2026, Medtronic’s MiniMed went public to advance wearable insulin pumps amid rising diabetes rates and market growth.

全球笔针市场预计将从2023年的35亿美元增长到2031年的85亿美元,主要是由于糖尿病率的上升,家庭医疗保健采用以及超细,更短的针和智能设备兼容等创新. The global pen needles market is projected to grow from $3.5 billion in 2023 to $8.5 billion by 2031, driven by rising diabetes rates, home healthcare adoption, and innovations like ultra-fine, shorter needles and smart device compatibility. 与此同时,由于糖尿病的流行和改善接入方式,胰岛素注射器市场预计将从2020年的156亿美元增长到2030年的24亿美元. Meanwhile, the insulin syringes market is expected to rise from $1.56 billion in 2020 to $2.40 billion by 2030, supported by diabetes prevalence and improved access. 2026年3月,Medtronic的MiniMed部门上市为下一代可穿戴胰岛素输送系统提供资金,而Insulet和Modular Medical则推进了其自动化和低成本补丁. In March 2026, Medtronic’s MiniMed division went public to fund next-gen wearable insulin delivery systems, while Insulet and Modular Medical advanced their automated and low-cost patch pumps. 一次性胰岛素正在迅速发展, 开放式循环系统主导美国市场, 北美因创新和基础设施而在全球领先. Disposable insulin pumps are growing rapidly, with open-loop systems dominating the U.S. market, and North America leading globally due to innovation and infrastructure.